Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.31 USD | +0.80% | -1.87% | +21.43% |
04-22 | TRxADE HEALTH, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-06 | Top Midday Gainers | MT |
Business Summary
Number of employees: 8
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Trxade, Inc.
77.4
%
| 5 | 47.5 % | 6 | 77.4 % | +17.78% |
Integra Pharma, LLC
16.5
%
| 5 | 41.5 % | 1 | 16.5 % | -71.31% |
Superlatus
5.9
%
| - | - | 0 | 5.9 % | - |
Unallocated
0.2
%
| 0 | 0.7 % | 0 | 0.2 % | -76.84% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 11 | 100.0 % | 8 | 100.0 % | -27.74% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Prashant Patel
FOU | Founder | 49 | 14/07/05 |
Chief Executive Officer | 53 | 14/07/05 | |
Jeff Davis
CTO | Chief Tech/Sci/R&D Officer | - | - |
Jay Morales
PRN | Corporate Officer/Principal | - | - |
Stevens D. Lee
LAW | General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 53 | 14/07/05 | |
Michael Peterson
BRD | Director/Board Member | 62 | 23/08/16 |
A. Newell
BRD | Director/Board Member | 66 | 29/09/22 |
Prashant Patel
FOU | Founder | 49 | 14/07/05 |
Donald Fell
BRD | Director/Board Member | 78 | 31/12/13 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,406,348 | 1,067,934 ( 75.94 %) | 0 | 75.94 % |
Company contact information
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+21.43% | 8.87M | |
+18.66% | 414B | |
+15.27% | 242B | |
+12.15% | 144B | |
+20.63% | 104B | |
+17.19% | 83.87B | |
+54.11% | 57.64B | |
+33.59% | 53.37B | |
+6.02% | 37.83B | |
+15.88% | 32.51B |
- Stock Market
- Equities
- MEDS Stock
- Company TRxADE HEALTH, Inc.